ASLAN Pharmaceuticals

Analysts estimated ASLN earnings of $-4.98 per share this quarter (Q1). ASLN's actual earnings were $-4.24 per share.

Analysts estimated ASLN earnings of $-0.66 per share this quarter (Q4). ASLN's actual earnings were $-0.78 per share.

Analysts estimated ASLN earnings of $-0.80 per share this quarter (Q3). ASLN's actual earnings were $-0.56 per share.